Nektar Gets $90 Million Jury Award in Breach Suit Vs Eli Lilly

By Colin KellaherNektar Therapeutics said it has won a $90 million verdict in its lawsuit against Eli Lilly related to the development of its proposed autoimmune drug Rezpegaldesleukin, or rezpeg.Nektar said a California jury found that Eli Lilly breached the implied covenant of good faith and fair…